Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.
about
Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuitsSilencing Neurons: Tools, Applications, and Experimental Constraints.Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.Viral strategies for targeting cortical circuits that control cocaine-taking and cocaine-seeking in rodents.DREADD-induced silencing of the medial amygdala reduces the preference for male pheromones and the expression of lordosis in estrous female mice.Thalamic inputs to dorsomedial striatum are involved in inhibitory control: evidence from the five-choice serial reaction time task in ratsArcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways.Noradrenergic Regulation of Central Amygdala in Aversive Pavlovian-to-Instrumental Transfer.A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling.Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source.Activation of endogenous arginine vasopressin neurons inhibit food intake: by using a novel transgenic rat line with DREADDs system.Chemogenetic inhibition of direct pathway striatal neurons normalizes pathological, cue-induced reinstatement of drug-seeking in rats.The Anterior Insular Cortex→Central Amygdala Glutamatergic Pathway Is Critical to Relapse after Contingency Management.Functional role for suppression of the insular-striatal circuit in modulating interoceptive effects of alcohol.Functional role for cortical-striatal circuitry in modulating alcohol self-administration.Kisspeptin neurones in the posterodorsal medial amygdala modulate sexual partner preference and anxiety in male mice.Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner.The use of chemogenetics in behavioural neuroscience: Receptor variants, targeting approaches, and caveats.Neuromodulation of orexin neurons reduces diet-induced adiposity.Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats.Chemogenetic excitation of accumbens-projecting infralimbic cortical neurons blocks toluene-induced conditioned place preference.Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.Chemogenetic inhibition reveals midline thalamic nuclei and thalamo-accumbens projections mediate cocaine-seeking in rats.Applications of optogenetic and chemogenetic methods to seizure circuits: Where to go next?Circuit and Synaptic Plasticity Mechanisms of Drug Relapse.Resisting the Urge to Act: DREADDs Modifying Habits.Chemogenetic Tools for Causal Cellular and Neuronal Biology.Dose-dependent reduction in cocaine-induced locomotion by Clozapine-N-Oxide in rats with a history of cocaine self-administration.Reduced Orexin System Function Contributes to Resilience to Repeated Social Stress.The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice.Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy.Dynamic interaction of local and transhemispheric networks is necessary for progressive intensification of hippocampal seizures.Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons.Chemogenetic Enhancement of Axon Regeneration Following Peripheral Nerve Injury in the SLICK-A Mouse.Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral NeuroscienceRegulation of striatal cells and goal-directed behavior by cerebellar outputs
P2860
Q28071885-B4CEC8D9-87BE-4370-98A4-7D1A8EC4377FQ38643921-1767EAA4-8517-424F-A07B-D08830B2D2FCQ39151291-47173F73-1037-4B9C-AEBA-C14E80A9B737Q39335378-2A48ADB7-7449-4D23-99EC-4E1572423039Q40135108-CBD98DE9-93FA-4328-A2EF-3AD1960308FEQ41192028-7DBED0A0-56BC-4855-AFB2-579FBB4EB8DDQ41661642-4B1C8415-97F0-4526-95EC-95C2BB20F1EBQ42642590-F7D86F30-EF69-4B7D-8F65-9D7257F13034Q43733721-C35AFFE0-85E9-4806-9A80-A16BAB6466EFQ45872691-40540965-21A6-4496-A116-0E201BB7ADEFQ47133477-062EBE0D-ADA1-435F-86F0-1DE365C68F57Q47297200-1722CE3B-4B1B-463B-B17F-79578A5F88EDQ47314757-889D4148-AB56-4748-9682-67D18E52CFFFQ47317970-529ABA26-4C65-464B-BFC3-A4EBEB15729BQ47401419-05123440-284C-4BAD-9B87-DCBB06D1B67CQ47550512-B462A0CB-FDCB-4C40-AD0F-E4A48725ADD7Q47552987-72039284-16FC-4150-A50E-26A7A29F8922Q47553027-72E5921E-761A-4A53-BCDE-5FB0A9DE4914Q47572257-6E5D85C4-DB75-4E78-93EF-24E64896DF64Q47654954-B2415D17-5928-47B3-A2FF-6895A258D1D4Q47873589-1A1FB535-B37B-4428-A03C-9E1E52B2DFA6Q48096641-FEEB3C8B-C99B-48C1-AC0E-8B4312914E89Q48196759-DB735107-405F-42F6-A400-72BDAE560BECQ48268811-A935A558-FB01-48C5-AA35-EE4400D53ADCQ48339388-6FEA0548-4773-44C2-B723-DC229BC47853Q48349295-77C183AA-1369-44AF-9CDF-E41C5478DF4BQ49917397-2BE7D3B5-0B25-4BF1-84E5-09481EEE23EEQ51735802-FA8498E1-B8E6-4F36-AB69-E285C5A1FCA4Q52584181-B38E776E-AF64-491B-A72F-2128265075B2Q52678173-3817E7A2-D616-48BA-96A0-7D71668DEB85Q53435364-AB896A39-C747-435C-9274-7EFA1361AF58Q55001496-7E41A107-FDFB-4277-8A3E-E1B2D0AE5C50Q55223005-1B3B79C6-6CB1-4E43-B1FA-E946D278F148Q55265234-16F12F8F-1742-4E34-B594-A25FE3890EC3Q57169426-0F7C8939-5B3D-4EBB-BC30-3BCD6B40CA2FQ58797740-52558D25-0F70-4D5B-A406-23587E548CD2
P2860
Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@ast
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@en
type
label
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@ast
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@en
prefLabel
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@ast
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@en
P2093
P2860
P1433
P1476
Clozapine N-Oxide Administrati ...... Designing DREADD Experiments.
@en
P2093
Duncan A A MacLaren
Prachi Khare
Richard W Browne
Rodrigo A España
Sandhya Krishnan Radhakrishnan
Stewart D Clark
P2860
P356
10.1523/ENEURO.0219-16.2016
P577
2016-09-01T00:00:00Z